Stem Cells: The Next Steps
Tags: STEM cells; BIOETHICS
Related Articles
- How to Think about Stemming an Insurgency. Kaebnick, Gregory E. // Hastings Center Report;Nov/Dec2004, Vol. 34 Issue 6, p2
Introduces a series of articles about stem cell research and bioethics.
- stem cells storm D.C. Sinha, Gunjan // Popular Science;Jan2002, Vol. 260 Issue 1, p58
Focuses on the ethical issues about the use of stem cells in medical research in the United States. Significant research on stem cells; Opposition on the technology; Government policy on the issues.
- The Basics About Stem Cells. Condic, Maureen L. // Human Life Review;Winter/Spring2002, Vol. 28 Issue 1/2, p119
Discusses issues pertaining to research on embryonic stem cells. Questions raised by the use of human embryos in medical research; Scientific arguments against the use of embryonic stem cells as a treatment for disease and injury; Advantages of using adult stem cells for research.
- ES Cell Research: In the Shadow of the Ban. Johnston, Josephine // Hastings Center Report;Mar/Apr2004, Vol. 34 Issue 2, p49
Speculates the reason behind the national and international interest in human embryonic stem (ES) cells despite the U.S. ban on federal funding of such research. Details on how to procure ES cells; Requirement of the government for ES cell research funds.
- Embryonic stem cell research and the argument of complicity. Birnbacher, Dieter // Reproductive BioMedicine Online;2009 Supplement 1, Vol. 18 Issue S1, p12
While the argument of complicity is only rarely discussed in bioethics, it is of obvious relevance to the issue of imported embryonic stem cells in countries in which the derivation of stem cells from early human embryos is legally prohibited and/or morally rejected. Complicity means that making...
- Stem cell patenting. Baldock, Claire // Journal of Commercial Biotechnology;Jan2006, Vol. 12 Issue 2, p120
The patenting of embryonic stem cell-related inventions appears to be as controversial as the technology itself. The author outlines the state of play in Europe and the USA as well as other selected territories. While Europe has the broadest statutory exclusions to patenting of inventions which...
- An Overview on Stem Cell Research and Regulatory Issues. Cogle, Christopher R.; Guthrie, Steven M.; Sanders, Ronald C.; Allen, William L.; Scott, Edward W.; Petersen, Bryon E. // Mayo Clinic Proceedings;Aug2003, Vol. 78 Issue 8, p993
Stem cells are noted for their ability to self-renew and differentiate into a variety of cell types. Some stem cells, described as totipotent cells, have tremendous capacity to self-renew and differentiate. Embryonic stem cells have pluripotent capacity, able to form tissues of all 3 germ layers...
- The Bioethics of iPS Cell-Based Drug Discovery. Hyun, I. // Clinical Pharmacology & Therapeutics;May2011, Vol. 89 Issue 5, p646
The ability to generate human induced pluripotent stem (iPS) cells presents exciting prospects for drug discovery and the development of safer, more effective drugs. Given the enormous potential for iPS cellbased drug development, what ethical issues could possibly cloud this new biomedical horizon?
- APPENDIX F. // Human Life Review;Spring2003, Vol. 29 Issue 2, p105
Reports on the meeting agenda of the Council on Bioethics in the U.S. Research work on adult stem cells; Practice of human cloning; Scientific and medical considerations to justify the ban on human reproductive cloning.
